1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Stem Cell Transplantation: Promise in Cancer Treatments and Blood Disorders"}],["$","meta","1",{"name":"description","content":"Bone marrow transplantation has been in clinical use for more than 30 years. Today, bone marrow transplantation is more commonly referred to as stem cell transplantation, as stem cells can be obtained from several other sources other than the bone marrow, including the peripheral blood and umbilical cord blood. Stem cell transplantation is commonly used for a variety of malignant disorders such as leukemias and lymphomas. However, it is also used for a number of other diseases such as immune deficiency states and non-malignant blood disorders. Dr. Bishop will discuss current research efforts that focus on increasing the application of stem cell transplantation to a broader patient population by increasing the potential stem cell donor pool, decreasing transplant-related toxicities and investigating its use in diseases not commonly treated with stem cell transplantation.\n\n

\nFor more information, visit
\nMedicine for the Public
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Stem Cell Transplantation: Promise in Cancer Treatments and Blood Disorders"}],["$","meta","4",{"property":"og:description","content":"Bone marrow transplantation has been in clinical use for more than 30 years. Today, bone marrow transplantation is more commonly referred to as stem cell transplantation, as stem cells can be obtained from several other sources other than the bone marrow, including the peripheral blood and umbilical cord blood. Stem cell transplantation is commonly used for a variety of malignant disorders such as leukemias and lymphomas. However, it is also used for a number of other diseases such as immune deficiency states and non-malignant blood disorders. Dr. Bishop will discuss current research efforts that focus on increasing the application of stem cell transplantation to a broader patient population by increasing the potential stem cell donor pool, decreasing transplant-related toxicities and investigating its use in diseases not commonly treated with stem cell transplantation.\n\n

\nFor more information, visit
\nMedicine for the Public
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/982b2268-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/e4c74e5e-84c6-4c4e-bb0f-bf407dd21af4.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Stem Cell Transplantation: Promise in Cancer Treatments and Blood Disorders"}],["$","meta","11",{"name":"twitter:description","content":"Bone marrow transplantation has been in clinical use for more than 30 years. Today, bone marrow transplantation is more commonly referred to as stem cell transplantation, as stem cells can be obtained from several other sources other than the bone marrow, including the peripheral blood and umbilical cord blood. Stem cell transplantation is commonly used for a variety of malignant disorders such as leukemias and lymphomas. However, it is also used for a number of other diseases such as immune deficiency states and non-malignant blood disorders. Dr. Bishop will discuss current research efforts that focus on increasing the application of stem cell transplantation to a broader patient population by increasing the potential stem cell donor pool, decreasing transplant-related toxicities and investigating its use in diseases not commonly treated with stem cell transplantation.\n\n

\nFor more information, visit
\nMedicine for the Public
"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}